Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro

Autor: MI Dawson, R Morosetti, S Pakkala, W Chao, Hironori Ueno, Y. Ikeda, DL Chen, HP Koeffler, M Morikawa, M Pfahl, Masahiro Kizaki, E Elster, R Heyman, D Heber

Publikováno v: Scopus-Elsevier

The biologic effects of retinoids such as all-trans-retinoic acid (ATRA) and 9-cis-retinoic acid on proliferation and differentiation of hematopoietic cells are mediated by binding and activating two distinct families of transcription factors: the re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107b232f2f2ed92388aafbaaecbf9bf4
https://doi.org/10.1182/blood.v87.5.1977.1977

9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro

Autor: JF Cameron, Masahiro Kizaki, MI Dawson, S. Pakkala, H P Koeffler, N Tsuruoka, A Sakashita, GJ Schiller, R Tomosaki

Publikováno v: Blood. 81:1009-1016

Retinoic acid exhibits effects on the proliferation and differentiation of many hematopoietic cells. Cellular responsiveness to retinoic acid (RA) is conferred through two distinct classes of nuclear receptors, the RA receptors (RARs) and the retinoi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f640bb77fd48a6ff1a6cbc921980ba4
https://doi.org/10.1182/blood.v81.4.1009.bloodjournal8141009

95. Effect of retinoids on the anchorage-independent growth of JB6 epidermal cells

Autor: CJ Rudd, MI Dawson, K Suing

Publikováno v: Biomedicine & Pharmacotherapy. 46:285

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7581b09aaf5eae51edb186b12ae9b1f
https://doi.org/10.1016/0753-3322(92)90180-f

Oxidized analogs of Di(1 H -indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity.

Autor: Sanchez M; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Xia Z; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Rico-Bautista E; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Cao X; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Cuddy M; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Castro DJ; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.; Oregon Health and Science University School of Medicine, Portland, OR, USA., Correa RG; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Chen L; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Yu J; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Bobkov A; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Ruvolo V; Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, USA., Andreeff M; Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, USA., Oshima RG; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA., Matsuzawa SI; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.; Present address: Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Reed JC; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.; Present address: Roche, Pharma Research and Early Development, Basel, Switzerland., Zhang XK; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.; School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research and Center for Stress Signaling Networks, Xiamen University, Xiamen, China., Hansel D; Department of Pathology, University of California San Diego, San Diego, CA, USA., Wolf DA; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.; School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research and Center for Stress Signaling Networks, Xiamen University, Xiamen, China., Dawson MI; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.

Publikováno v: Oncotarget [Oncotarget] 2018 May 18; Vol. 9 (38), pp. 25057-25074. Date of Electronic Publication: 2018 May 18 (Print Publication: 2018).

NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells.

Autor: Murshed F; Department of Oncology, John D Dingell VA Medical Center, 11M-HO, Room C3687, 4646 John R Street, Detroit, MI, 48201, USA., Farhana L, Dawson MI, Fontana JA

Publikováno v: Apoptosis : an international journal on programmed cell death [Apoptosis] 2014 Mar; Vol. 19 (3), pp. 506-17.